Boston Scientific Corporation

May 01, 2026 • Author: Phil Ratcliff

Item	Proposal	Vote
1	Proposal to elect ten Directors.
1a	David C. Habiger	✓ For(164.083)
1b	Edward J. Ludwig	✓ For(164.083)
1c	Michael F. Mahoney	✗ Against(164.083)
1d	Jessica L. Mega	✓ For(164.083)
1e	Susan E. Morano	✓ For(164.083)
1f	Cheryl Pegus	✓ For(164.083)
1g	Cathy R. Smith	✓ For(164.083)
1h	Christophe P. Weber	✓ For(164.083)
1i	David S. Wichmann	✓ For(164.083)
1j	Ellen M. Zane	✓ For(164.083)
2	To approve, on a non-binding, advisory basis, the compensation of our named executive officers.	✓ For(164.083)
3	To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the 2026 fiscal year.	✓ For(164.083)
4	To amend our Employee Stock Purchase Plan to increase the number of shares reserved for issuance.	✓ For(164.083)
5	To amend our Certificate of Incorporation to remove supermajority voting provisions.	✓ For(164.083)
6	To amend our Certificate of Incorporation to provide for exculpation of certain officers as permitted by Delaware law.	✓ For(164.083)
7	To amend our Certificate of Incorporation and By-Laws to permit stockholders holding 25% of our common stock to call a special meeting of stockholders.	✓ For(164.083)
8	Stockholder proposal titled "Give Shareholders the Ability to Call for a Special Shareholder Meeting."	✗ Against(164.083)

Attachments

📄

Boston_Scientific_Proxy_Statement.pdf 31.8 MB

This article was written for information purposes only and its content should not be construed by any consumer and/or prospective client as rebel Financial's solicitation to affect, or attempt to affect transactions in securities, or the rendering of personalized investment advice for compensation. No client or prospective client should assume that any such discussion serves as the receipt of, or a substitute for, personalized advice from rebel Financial, or from any other investment professional. See our disclosures page for more information.